Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 5

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 5
---
”) (collectively, the “ADC Programs”). |

| 3. | Equity Plan Increase Proposal. To approve an amendment to the Aadi Bioscience, Inc. 2021 Equity                                                                                                                                 
 Incentive Plan (the “2021 Plan”) to (i) increase the shares available for issuance under the 2021 Plan by 6,300,000 shares from 2,000,284 shares to 8,300,284 shares and (ii) increase the 2021 Plan’s default annual automatic 
 share reserve increase occurring on January 1 of each year from 4% of outstanding shares on the last day of the immediately preceding fiscal year to 5% (the “Equity Plan Increase Proposal”).                                  |

| 4. | Non-Binding Advisory Vote on Golden Parachutes Proposal. To                                                                                                                                                  
 approve, on a non-binding, advisory basis, certain compensation that will or may become payable to our named executive officers in connection with the Divestiture (the “Non-Binding Advisory Vote on Golden 
 Parachutes Proposal”).                                                                                                                                                                                       |

| 5. | Adjournment Proposal. To approve one or more adjournments of the Special Meeting, if necessary or                                                                                                                                        
 appropriate and to the extent permitted by the Divestiture Agreement, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Divestiture Proposal (the “Adjournment Proposal”). |

As noted above, our Special Meeting will be a “virtual meeting” of stockholders, which will be conducted exclusively online at a virtual web conference. There will not be a physical meeting location, and stockholders will not be able to attend the Special Meeting in person. You will be able to attend the Special Meeting virtually by visiting www.virtualshareholdermeeting.com/AADI2025SM, where you will be able to listen to the Special Meeting live, submit questions and vote online by entering the control number on your proxy card or voter instruction form. Attending the Special Meeting and voting your shares thereat will have the effect of revoking any proxy that you previously submitted to vote your shares. Our board of directors unanimously recommends that you vote “FOR” each of the (1) Divestiture Proposal, (2) PIPE Financing Proposal, (3) Equity Plan Increase Proposal, (4) Non-BindingAdvisory Vote on Golden Parachutes Proposal and (5) Adjournment Proposal, as outlined in the attached proxy statement. Whether or not you plan to attend the Special Meeting